P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968336.17893.02 |
| _version_ | 1797281680373841920 |
|---|---|
| author | Armin Ghobadi Ibrahim Aldoss Shannon Maude Alan S Wayne Deepa Bhojwani Ashish Bajel Bhagirathbhai Dholaria Rawan Faramand Ryan Mattison Michael Rettig Ouiam Bakkacha John Muth Angela Pannunzio Brett Ramsey Eileen Mcnulty Matthew Cooper Jan Davidson-Moncada Kenneth Jacobs John Dipersio |
| author_facet | Armin Ghobadi Ibrahim Aldoss Shannon Maude Alan S Wayne Deepa Bhojwani Ashish Bajel Bhagirathbhai Dholaria Rawan Faramand Ryan Mattison Michael Rettig Ouiam Bakkacha John Muth Angela Pannunzio Brett Ramsey Eileen Mcnulty Matthew Cooper Jan Davidson-Moncada Kenneth Jacobs John Dipersio |
| author_sort | Armin Ghobadi |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:00:56Z |
| format | Article |
| id | doaj.art-54e632fd8a1741b4b44130773003313c |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:00:56Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-54e632fd8a1741b4b44130773003313c2024-03-03T03:24:17ZengWileyHemaSphere2572-92412023-08-017e178930210.1097/01.HS9.0000968336.17893.02202308003-00258P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)Armin Ghobadi0Ibrahim Aldoss1Shannon Maude2Alan S Wayne3Deepa Bhojwani4Ashish Bajel5Bhagirathbhai Dholaria6Rawan Faramand7Ryan Mattison8Michael Rettig9Ouiam Bakkacha10John Muth11Angela Pannunzio12Brett Ramsey13Eileen Mcnulty14Matthew Cooper15Jan Davidson-Moncada16Kenneth Jacobs17John Dipersio181 Washington University School of Medicine, St. Louis, United States2 City of Hope, Duarte, United States3 Children’s Hospital of Philadelphia, Philadelphia, United States4 Children’s Hospital Los Angeles, Los Angeles, United States4 Children’s Hospital Los Angeles, Los Angeles, United States5 Peter Mac Callum Cancer Institute, Melbourne, Australia6 Vanderbilt University Medical Center7 Moffitt Cancer Center, Tampa, United States8 University of Wisconsin, Madison, United States1 Washington University School of Medicine, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States9 Wugen, St. Louis, United States1 Washington University School of Medicine, St. Louis, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000968336.17893.02 |
| spellingShingle | Armin Ghobadi Ibrahim Aldoss Shannon Maude Alan S Wayne Deepa Bhojwani Ashish Bajel Bhagirathbhai Dholaria Rawan Faramand Ryan Mattison Michael Rettig Ouiam Bakkacha John Muth Angela Pannunzio Brett Ramsey Eileen Mcnulty Matthew Cooper Jan Davidson-Moncada Kenneth Jacobs John Dipersio P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) HemaSphere |
| title | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_full | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_fullStr | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_full_unstemmed | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_short | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_sort | p356 phase 1 2 dose escalation study of anti cd7 allogenic car t cell in relapsed or refractory r r t cell acute lymphoblastic leukemia lymphoblastic lymphoma t all lbl |
| url | http://journals.lww.com/10.1097/01.HS9.0000968336.17893.02 |
| work_keys_str_mv | AT arminghobadi p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT ibrahimaldoss p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT shannonmaude p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT alanswayne p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT deepabhojwani p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT ashishbajel p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT bhagirathbhaidholaria p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT rawanfaramand p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT ryanmattison p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT michaelrettig p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT ouiambakkacha p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT johnmuth p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT angelapannunzio p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT brettramsey p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT eileenmcnulty p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT matthewcooper p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT jandavidsonmoncada p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT kennethjacobs p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT johndipersio p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl |